We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTK icon
3726
Flotek Industries
FTK
$1.28B
$1.62K ﹤0.01%
366
-1
-0.3% -$5
CMCM
3727
Cheetah Mobile
CMCM
$96.5M
$1.61K ﹤0.01%
816
DAVE icon
3728
Dave Inc
DAVE
$4.06B
$1.61K ﹤0.01%
254
TDCX
3729
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$1.59K ﹤0.01%
+270
New +$1.77K
AHI
3730
DELISTED
Advanced Health Intelligence Ltd
AHI
$1.57K ﹤0.01%
+630
New +$2.38K
CRON
3731
Cronos Group
CRON
$1.14B
$1.57K ﹤0.01%
785
CBIO
3732
Crescent Biopharma
CBIO
$626M
$1.57K ﹤0.01%
10
RDHL
3733
Redhill Biopharma
RDHL
$3.68M
$1.54K ﹤0.01%
121
CVM icon
3734
CEL-SCI Corp
CVM
$30.1M
$1.52K ﹤0.01%
41
PDLI
3735
DELISTED
PDL BioPharma, Inc.
PDLI
$1.51K ﹤0.01%
612
GRFX
3736
DELISTED
Graphex Group
GRFX
$1.5K ﹤0.01%
264
+232
+725% +$1.43K
AMRN
3737
Amarin Corp
AMRN
$303M
$1.48K ﹤0.01%
80
+10
+14% +$217
AMTD
3738
AMTD IDEA Group
AMTD
$72.6M
$1.47K ﹤0.01%
398
+393
+7,860% +$1.64K
CIAN
3739
DELISTED
Cian PLC American Depositary Shares, each representing one Ordinary Share
CIAN
$1.46K ﹤0.01%
430
CURO
3740
DELISTED
CURO Group Holdings Corp.
CURO
$1.46K ﹤0.01%
1,388
-88,563
-98% -$119K
ARQ icon
3741
Arq
ARQ
$89.3M
$1.45K ﹤0.01%
816
PXLW icon
3742
Pixelworks
PXLW
$41.6M
$1.41K ﹤0.01%
104
GTHX
3743
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.39K ﹤0.01%
967
QTTB icon
3744
Q32 Bio
QTTB
$464M
$1.37K ﹤0.01%
65
NEUP
3745
Neuphoria Therapeutics
NEUP
$20.6M
$1.36K ﹤0.01%
+42
New +$905
XIN
3746
DELISTED
Xinyuan Real Estate
XIN
$1.36K ﹤0.01%
470
APLT
3747
DELISTED
Applied Therapeutics
APLT
$1.35K ﹤0.01%
544
TRIB
3748
Trinity Biotech
TRIB
$8.39M
$1.35K ﹤0.01%
12
DIBS icon
3749
1stdibs.com
DIBS
$171M
$1.33K ﹤0.01%
366
-2,614
-88% -$10.4K
HYFM icon
3750
Hydrofarm Holdings
HYFM
$7.62M
$1.33K ﹤0.01%
109
-384
-78% -$4.29K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.